Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Herbsland recall

This article was originally published in The Tan Sheet

Executive Summary

All 100-tablet bottles of Ancom Anti-Hypertensive Compound Tablets recalled by Herbsland because they contain several Rx drug ingredients, including reserpine, diazepam, promethiazine, company says Jan. 17. Product is "unapproved new drug" and "poses possible serious health risks including sedation, depression and potentially life-threatening abnormalities of the blood," 1Herbsland press release says, although no adverse events have been reported. Sold through distributors, retail stores in the New York metropolitan area and over the Internet, Ancom tablets are labeled for anti-hypertensive use and come in white plastic bottles with an outer cardboard holding carton. Manufacturer is listed as Chinese firm Shanghai Pharmaceutical Industry...
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS095031

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel